150 related articles for article (PubMed ID: 38644281)
1. [Precision diagnosis and therapeutic intervention of Alport syndrome].
Di HL; Liu ZH
Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(16):1347-1350. PubMed ID: 38644281
[TBL] [Abstract][Full Text] [Related]
2. Alport Syndrome: Achieving Early Diagnosis and Treatment.
Kashtan CE
Am J Kidney Dis; 2021 Feb; 77(2):272-279. PubMed ID: 32712016
[TBL] [Abstract][Full Text] [Related]
3. Women and Alport syndrome.
Rheault MN
Pediatr Nephrol; 2012 Jan; 27(1):41-6. PubMed ID: 21380623
[TBL] [Abstract][Full Text] [Related]
4. Genetic testing and glomerular hematuria-A nephrologist's perspective.
Kashtan CE
Am J Med Genet C Semin Med Genet; 2022 Sep; 190(3):399-403. PubMed ID: 35775584
[TBL] [Abstract][Full Text] [Related]
5. Guidelines for Genetic Testing and Management of Alport Syndrome.
Savige J; Lipska-Zietkiewicz BS; Watson E; Hertz JM; Deltas C; Mari F; Hilbert P; Plevova P; Byers P; Cerkauskaite A; Gregory M; Cerkauskiene R; Ljubanovic DG; Becherucci F; Errichiello C; Massella L; Aiello V; Lennon R; Hopkinson L; Koziell A; Lungu A; Rothe HM; Hoefele J; Zacchia M; Martic TN; Gupta A; van Eerde A; Gear S; Landini S; Palazzo V; Al-Rabadi L; Claes K; Corveleyn A; Van Hoof E; van Geel M; Williams M; Ashton E; Belge H; Ars E; Bierzynska A; Gangemi C; Renieri A; Storey H; Flinter F
Clin J Am Soc Nephrol; 2022 Jan; 17(1):143-154. PubMed ID: 34930753
[TBL] [Abstract][Full Text] [Related]
6. Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.
Kamiyoshi N; Nozu K; Fu XJ; Morisada N; Nozu Y; Ye MJ; Imafuku A; Miura K; Yamamura T; Minamikawa S; Shono A; Ninchoji T; Morioka I; Nakanishi K; Yoshikawa N; Kaito H; Iijima K
Clin J Am Soc Nephrol; 2016 Aug; 11(8):1441-1449. PubMed ID: 27281700
[TBL] [Abstract][Full Text] [Related]
7. Could This Be Alport Syndrome?
Lennon R; Fornoni A
Clin J Am Soc Nephrol; 2021 Nov; 16(11):1743-1745. PubMed ID: 33849931
[No Abstract] [Full Text] [Related]
8. Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working Group.
Kashtan CE; Ding J; Garosi G; Heidet L; Massella L; Nakanishi K; Nozu K; Renieri A; Rheault M; Wang F; Gross O
Kidney Int; 2018 May; 93(5):1045-1051. PubMed ID: 29551517
[TBL] [Abstract][Full Text] [Related]
9. COL4A3 mutation is an independent risk factor for poor prognosis in children with Alport syndrome.
Ozdemir G; Gulhan B; Atayar E; Saygılı S; Soylemezoglu O; Ozcakar ZB; Eroglu FK; Candan C; Demir BK; Soylu A; Yüksel S; Alpay H; Agbas A; Duzova A; Hayran M; Ozaltin F; Topaloglu R
Pediatr Nephrol; 2020 Oct; 35(10):1941-1952. PubMed ID: 32394188
[TBL] [Abstract][Full Text] [Related]
10. [Research progress in diagnosis, treatment and management of Alport syndrome].
Chen ZJ; Zhang X; Lin ZF; Yu ZH
Zhonghua Er Ke Za Zhi; 2022 Apr; 60(4):370-373. PubMed ID: 35385950
[TBL] [Abstract][Full Text] [Related]
11. Renal, auricular, and ocular outcomes of Alport syndrome and their current management.
Zhang Y; Ding J
Pediatr Nephrol; 2018 Aug; 33(8):1309-1316. PubMed ID: 28864840
[TBL] [Abstract][Full Text] [Related]
12. Milder clinical aspects of X-linked Alport syndrome in men positive for the collagen IV α5 chain.
Hashimura Y; Nozu K; Kaito H; Nakanishi K; Fu XJ; Ohtsubo H; Hashimoto F; Oka M; Ninchoji T; Ishimori S; Morisada N; Matsunoshita N; Kamiyoshi N; Yoshikawa N; Iijima K
Kidney Int; 2014 May; 85(5):1208-13. PubMed ID: 24304881
[TBL] [Abstract][Full Text] [Related]
13. [Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains].
Heidet L; Gubler MC
Nephrol Ther; 2016 Dec; 12(7):544-551. PubMed ID: 27816395
[TBL] [Abstract][Full Text] [Related]
14. What the Adult Nephrologist Should Know About Alport Syndrome.
Kashtan CE
Adv Chronic Kidney Dis; 2022 May; 29(3):225-230. PubMed ID: 36084969
[TBL] [Abstract][Full Text] [Related]
15. Alport syndrome: deducing the mode of inheritance from the presence of haematuria in family members.
Savige J
Pediatr Nephrol; 2020 Jan; 35(1):59-66. PubMed ID: 30506145
[TBL] [Abstract][Full Text] [Related]
16. Alport syndrome. Molecular genetic aspects.
Hertz JM
Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the current situation regarding diagnosis and treatment of Alport syndrome in Asian countries: results of survey of the Asian Paediatric Nephrology association (AsPNA) tubular and inherited working group.
Nozu K; Resontoc LPR; Hooman N; Vasudevan A; Ding J; Kang HG
Clin Exp Nephrol; 2023 Sep; 27(9):776-780. PubMed ID: 37289334
[TBL] [Abstract][Full Text] [Related]
18. A female with X-linked Alport syndrome and compound heterozygous COL4A5 mutations.
Mohammad M; Nanra R; Colville D; Trevillian P; Wang Y; Storey H; Flinter F; Savige J
Pediatr Nephrol; 2014 Mar; 29(3):481-5. PubMed ID: 24337245
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Genetic Features of Autosomal Dominant Alport Syndrome: A Cohort Study.
Furlano M; Martínez V; Pybus M; Arce Y; Crespí J; Venegas MDP; Bullich G; Domingo A; Ayasreh N; Benito S; Lorente L; Ruíz P; Gonzalez VL; Arlandis R; Cabello E; Torres F; Guirado L; Ars E; Torra R
Am J Kidney Dis; 2021 Oct; 78(4):560-570.e1. PubMed ID: 33838161
[TBL] [Abstract][Full Text] [Related]
20. Ocular features in Alport syndrome: pathogenesis and clinical significance.
Savige J; Sheth S; Leys A; Nicholson A; Mack HG; Colville D
Clin J Am Soc Nephrol; 2015 Apr; 10(4):703-9. PubMed ID: 25649157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
